We are live on ! Find out more
SAM

Shikiar Asset Management Portfolio holdings

AUM $396M
1-Year Est. Return 41.06%
This Fund
S&P 500
This Quarter Est. Return
+25.54%
1 Year Est. Return
+41.06%
3 Year Est. Return
+97.84%
5 Year Est. Return
10 Year Est. Return
AUM
$396M
AUM Growth
+$49M
Cap. Flow
-$543K
Cap. Flow %
-0.14%
Top 10 Hldgs %
51.33%
Holding
117
New
14
Increased
24
Reduced
50
Closed
4

Top Sells

Rank Stock Value
1
CBRE icon
CBRE Group
CBRE
+$4.15M
2
COF icon
Capital One
COF
+$3.73M
3
FCX icon
Freeport-McMoran
FCX
+$3.48M
4
ZS icon
Zscaler
ZS
+$1.84M
5
SLM icon
SLM Corp
SLM
+$1.74M

Sector Composition

Rank Sector Weight
1 Technology 36.23%
2 Miscellaneous 14.65%
3 Financials 12.21%
4 Healthcare 8.08%
5 Materials 5.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASYS icon
76
Amtech Systems
ASYS
$264M
$509K 0.13%
+22,075
New +$419K
JNJ icon
77
Johnson & Johnson
JNJ
$646B
$483K 0.12%
1,900
MCD icon
78
McDonald's
MCD
$188B
$472K 0.12%
1,745
CORZ icon
79
Core Scientific
CORZ
$5.31B
$444K 0.11%
17,350
-2,925
-14% -$68.9K
ETW
80
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ETW
$1.08B
$435K 0.11%
45,100
NVDA icon
81
NVIDIA
NVDA
$5.25T
$422K 0.11%
2,110
OGE icon
82
OGE Energy
OGE
$9.45B
$414K 0.1%
+8,500
New +$407K
INTC icon
83
Intel
INTC
$473B
$359K 0.09%
+2,570
New +$260K
ETV
84
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
ETV
$1.81B
$343K 0.09%
23,075
LLY icon
85
Eli Lilly
LLY
$1.05T
$341K 0.09%
284
URGN icon
86
UroGen Pharma
URGN
$2.13B
$322K 0.08%
8,750
-2,000
-19% -$54.2K
OTLY
87
Oatly Group
OTLY
$468M
$318K 0.08%
34,000
+10,000
+42% +$103K
CRWV
88
CoreWeave
CRWV
$46.5B
$314K 0.08%
3,150
EPD icon
89
Enterprise Products Partners
EPD
$84.3B
$312K 0.08%
8,500
OCC icon
90
Optical Cable Corp
OCC
$120M
$306K 0.08%
14,600
-13,550
-48% -$188K
PANW icon
91
Palo Alto Networks
PANW
$303B
$297K 0.08%
872
-297
-25% -$68K
ONDS icon
92
Ondas Inc
ONDS
$4.51B
$294K 0.07%
35,700
+18,950
+113% +$187K
TGEN
93
Tecogen Inc
TGEN
$93.9M
$282K 0.07%
54,050
+36,400
+206% +$182K
XRN
94
Chiron Real Estate Inc
XRN
$487M
$281K 0.07%
+7,500
New +$266K
PEP icon
95
PepsiCo
PEP
$193B
$278K 0.07%
2,050
WM icon
96
Waste Management
WM
$87.8B
$253K 0.06%
1,133
-160
-12% -$35.6K
SOLS
97
Solstice Advanced Materials
SOLS
$10.1B
$252K 0.06%
2,843
-741
-21% -$61.1K
PG icon
98
Procter & Gamble
PG
$334B
$248K 0.06%
1,690
ETG
99
Eaton Vance Tax-Advantaged Global Dividend Income Fund
ETG
$1.86B
$247K 0.06%
10,500
LRCX icon
100
Lam Research
LRCX
$378B
$247K 0.06%
+569
New +$173K

Similar funds

Shikiar Asset Management's Q2 2026 Portfolio in Review

As of Q2 2026, Shikiar Asset Management held 117 positions worth $396M, up 14% from $347M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Shikiar Asset Management's Q2 2026 filing shows 14 new, 24 increased, 50 reduced and 4 closed positions. Its largest new stake was Revolution Medicines: 33,205 shares worth $6.22M. The largest sale was CBRE Group, an estimated $4.15M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 31% a quarter earlier, followed by Miscellaneous and Financials.

  • Shikiar Asset Management's largest Q2 2026 buy was Revolution Medicines: 33,205 shares worth $6.22M.
  • Shikiar Asset Management added most to Madrigal Pharmaceuticals in Q2 2026, an estimated $5.61M increase.
  • Shikiar Asset Management's biggest Q2 2026 reduction was CBRE Group, cutting an estimated $4.15M.
  • Shikiar Asset Management fully exited FTAI Aviation 8.25% Series C Preferred Shares in Q2 2026, selling an estimated $798K.
  • Shikiar Asset Management's ten largest holdings make up 51% of its $396M portfolio in Q2 2026.
  • Shikiar Asset Management opened 14 new positions and closed 4 in Q2 2026.
  • Shikiar Asset Management's portfolio value rose 14% quarter-over-quarter to $396M.

Based on Shikiar Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.